Skip to main content

Table 1 Baseline characteristics of participants who inject opioids and live with HIV in Vancouver, BC, stratified by the baseline HAT eligibility status

From: Eligibility for heroin-assisted treatment (HAT) among people who inject opioids and are living with HIV in a Canadian setting

Characteristic

Total (%) (n = 478)

HAT eligibility

p value

Yes (%)

45 (9.4)

No (%)

433 (90.6)

Age (median, inter-quartile range-IQR)b

43.1 (36.7–47.9)

36.7 (34.2–43.7)

43.5 (37.9–48.1)

< 0.001

Gender

    

 Male

321 (67.2)

23 (51.1)

298 (68.8)

0.016

 Non-male

157 (32.8)

22 (48.9)

135 (31.2)

 

Ethnicity

    

 Caucasian

273 (57.1)

29 (64.4)

244 (56.4)

0.296

 Non-Caucasian

205 (42.9)

16 (35.6)

189 (43.6)

 

Homelessnessa

    

 Yes

169 (35.4)

22 (48.9)

147 (33.9)

0.026

 No

305 (63.8)

21 (46.7)

284 (65.6)

 

Relationship statusa

    

 Legally married/common law/regular partner

126 (26.4)

15 (33.3)

111 (25.6)

0.228

 Other

339 (70.9)

28 (62.2)

311 (71.8)

 

Highest level of education completed

    

 ≥ high school diploma

229 (47.9)

23 (51.1)

206 (47.6)

0.512

 < high school diploma

241 (50.4)

20 (44.4)

221 (51.0)

 

Employmenta,c

    

 Yes

101 (21.1)

4 (8.9)

97 (22.4)

0.035

 No

377 (78.9)

41 (91.1)

336 (77.6)

 

Money spent on drugs p/dayc

    

 ≥ $50 p/day

315 (65.9)

39 (86.7)

276 (63.7)

< 0.001

 < $50 p/day

158 (33.1)

5 (11.1)

153 (35.3)

 

Drug dealinga

    

 Yes

148 (31.0)

25 (55.6)

123 (28.4)

< 0.001

 No

330 (69.0)

20 (44.4)

310 (71.6)

 

Years of using heroin injection heroin at baseline (median, IQR)b

    

 Number of years

14.8 (7.3–22.6)

15.7 (8.7–20.4)

14.4 (7.3–22.7)

0.640

Daily non-injection cocaine usea,c

    

 Yes

2 (0.4)

0 (0.0)

2 (0.5)

1.000

 No

476 (99.6)

45 (100.0)

431 (99.5)

 

Daily non-injection heroin usea,c

    

 Yes

4 (0.8)

1 (2.2)

3 (0.7)

0.328

 No

474 (99.2)

44 (97.8)

430 (99.3)

 

Daily crack usea

    

 Yes

181 (37.9)

25 (55.6)

156 (36.0)

0.010

 No

297 (62.1)

20 (44.4)

277 (64.0)

 

Daily crystal meth usea

    

 Yes

19 (4.0)

5 (11.1)

14 (3.2)

0.025

 No

459 (96.0)

40 (88.9)

419 (96.8)

 

Overdosea

    

 Yes

32 (6.7)

7 (15.6)

25 (5.8)

0.012

 No

446 (93.3)

38 (84.4)

408 (94.2)

 

Lent syringea,c

    

 Yes

17 (3.6)

3 (6.7)

14 (3.2)

0.210

 No

460 (96.2)

42 (93.3)

418 (96.5)

 

Recent incarcerationa

    

 Yes

75 (15.7)

12 (26.7)

63 (14.5)

0.034

 No

402 (84.1)

33 (73.3)

369 (85.2)

 

Engaged in any form of unprotected sexa,c

    

 Yes

46 (9.6)

5 (11.1)

41 (9.5)

0.790

 No

429 (89.7)

40 (88.9)

389 (89.8)

 

Exchanged sex for gifts, food, shelter, clothes, etc.a

    

 Yes

72 (15.1)

15 (33.3)

57 (13.2)

< 0.001

 No

403 (84.3)

30 (66.7)

373 (86.1)

 

Attacked, assaulted, or suffered violencea

    

 Yes

98 (20.5)

12 (26.7)

86 (19.9)

0.293

 No

377 (78.9)

33 (73.3)

344 (79.4)

 

HCVc

    

 Yes

429 (89.7)

40 (88.9)

389 (89.8)

0.797

 No

49 (10.3)

5 (11.1)

44 (10.2)

 

Plasma HIV-1 RNA viral load > 50 c/mL

    

 Yes

313 (65.5)

31 (68.9)

282 (65.1)

0.656

 No

162 (33.9)

14 (31.1)

148 (34.2)

 

On ART (≥ 1 day)a

    

 Yes

283 (59.2)

28 (62.2)

255 (58.9)

0.665

 No

195 (40.8)

17 (37.8)

178 (41.1)

 

CD4+ cell count per 100 cellsa,b

    

 Median, IQR

3.2 (2.0–4.8)

3.2 (1.6–5.0)

3.2 (2.0–4.8)

0.696

  1. aAll behavioural variables refer to the 6 months prior to the follow-up questionnaire
  2. bContinuous variable, p value is generated from Wilcoxon rank-sum test
  3. cp value is generated from Fisher’s exact test because of small cell count